# Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

> **NCT00799643** · PHASE2,PHASE3 · COMPLETED · sponsor: **Joslin Diabetes Center** · enrollment: 638 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Salsalate
- **DRUG:** Salsalate Placebo

## Key facts

- **NCT ID:** NCT00799643
- **Lead sponsor:** Joslin Diabetes Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2012-09
- **Final completion:** —
- **Target enrollment:** 638 (ACTUAL)
- **Last updated:** 2017-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00799643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00799643, "Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00799643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*